Late Breaking Abstract SubmissionThe World Allergy Congress (WAC) is now accepting late breaking abstracts for the upcoming Meeting, WAC 2007 in Bangkok. Late breaking abstract submission provides an opportunity for individuals to submit important research advance. A brief statement justifying why the abstract is important or late breaking is a submission requirement.
LATE BREAKING ABSTRACTSWhat is a late breaking abstract?
A late breaking abstract should describe an important and current research advance that has not been submitted previously.
Please note: The Late breaking abstract is not a second chance to submit a study for the second time in hopes that it might be selected for an oral presentation. Individuals listed as first authors of standard abstracts are not prohibited from submitting late-breaking abstracts, provided that the late breaking abstract describes a study different from the previously submitted study. Individuals submitting a late breaking abstract must indicate authors and co-authors that have already submitted a standard abstract.
The selection of abstracts will be based on scientific quality and novelty of research either in basic or clinical science. The selected abstracts will be presented as posters.
In order to be considered for presentation at the WAC 2007, late breaking abstracts must be submitted through this website. The submission deadline for late breaking abstracts is 30 September 2007 at 24.00 CET. For more information, contact Congrex at:
wac2007abstract@congrex.se Only abstracts not published elsewhere or submitted for presentation at another national and/or international meeting will be considered for presentation.
DEADLINE 30 SEPTEMBER 2007 AT 24.00 HOUR CET |
Abstracts received after 30 September will not be considered.Instructions to AuthorsREGISTRATION AND PAYMENT The presenting author must register for the Congress and pay the registration fee in order to view their abstract in the e-journal and the Program. The registration fee is refundable if the abstract is not accepted.
The presenting author of an accepted abstract is allowed to register with the early registration fee until 31 August 2007.
PASSPORT AND VISA Participants are advised to make their own arrangements with respect to entering Thailand. Allow at least two months handling of your visa application from the Thai Embassy/Consulat in your country.
ABSTRACT SUBMISSION Carefully read the guidelines printed in this announcement and the guidelines on the submission web site before submitting your abstract. Acknowledgement of the receipt of your submission will be returned to your e-mail address immediately upon submission. If you do not receive the confirmation e-mail, your abstract will need to be resubmitted.
SUBMISSION GUIDELINES Abstracts can only be submitted electronically through this web page.Deadline for abstract submission is 30 September 2007 at 24.00 CET.
Abstracts must be written in English and presentations must be in English. Accepted abstracts selected by expert reviewers will be in poster sessions. Poster presenters will be requested to stay by their posters during the Poster Session to deliver a “two minute take home message” and to answer questions from the audience.
In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study, the method used, the results observed, and the conclusions based upon the results. It is inadequate to state “The results will be discussed” or “The data will be presented”. You may subtitle the paragraphs in bold format in the following order: Background, Method, Results and Conclusion. The maximum length allowed for an abstract is 2,500 characters.
The abstract title and body text should only include pharmacopeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required the first time a drug is mentioned in the text.
References, credits or the authors’ academic degrees or grant support are not to be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text.
It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author. Please note that for each Congress a number of abstracts are rejected because they contain no data or the English is unacceptable.
From the Congress web site you can access your Personal Page by using your password included in the e-mail received upon submission.
TOPICS One of the following topics that best describes the abstract should be indicated with submission:
• Basic
• Clinical
NOTIFICATION OF ACCEPTANCE Notification of acceptance/rejection will be e-mailed by mid October (contact Congrex if you have not received your notification by then). The corresponding author will receive all correspondence concerning the abstract. The corresponding author is responsible for informing all authors of the status of the abstract. All abstract presenters will be asked to reconfirm their attendance after receiving the notification.
PUBLICATION OF ABSTRACTS Accepted abstracts will be published on a CD-ROM and/or on the Internet. The abstracts will be printed in the supplement to the WAO journal, Allergy & Clinical Immunology International Journal of the World Allergy Organization, which will be handed out at the Congress.
For submission support please contact the Congress secretariat at For submission support please contact the Congress secretariat at
wac2007abstract@congrex.se 
